Revenue
170 million USD
2026 Q2 · USD
Exact inputs and evidence
- Revenue: 169584000 USD Source
Annual consolidated revenue for 2025: about USD 490.7M, using the latest reported figures. The previous period, 2024, was about USD 233.2M.
170 million USD
2026 Q2 · USD
2.33%
2026 Q2 · %
58.1 million USD
2026 Q2 · USD
117735000 USD
46000000 USD
94174767 shares
5.69% · 5.07 million shares
Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.
The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.
591 million USD
2025-07-01 – 2026-06-30
-43.5 million USD
2025-07-01 – 2026-06-30
92.7 million USD
2025-07-01 – 2026-06-30
Includes later revisions to earlier periods. Annual charts exclude incomplete years.
Latest filing recorded: 2026-08-04.
Financial data available through: 2025-12-31.
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Prior period
USD 233.18 million
–
Current period
USD 490.73 million
–
490728000 − 233175000 = 257553000 USD
233175000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source490728000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
−USD 321.55 million
–
Current period
−USD 25.55 million
–
-25546000 − -321545000 = 295999000 USD
-321545000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source-25546000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
−USD 237.48 million
–
Current period
USD 37.78 million
–
37784000 − -237475000 = 275259000 USD
-237475000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source37784000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Comparable inputs unavailable for: Capital expenditure.
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
| Period | Revenue | Operating costs | Operating income | Tax, interest and other | Net income | Free cash flow | Source |
|---|---|---|---|---|---|---|---|
| 2016 2016-01-01 – 2016-12-31 | 133591000 | 191805000 Derived | -58214000 | -10311000 Derived | -47903000 | -4869000 Derived | Source
|
| 2017 2017-01-01 – 2017-12-31 | 154937000 | 208728000 Derived | -53791000 | 5940000 Derived | -59731000 | 6516000 Derived | Source
|
| 2018 2018-01-01 – 2018-12-31 | 164246000 | 244286000 Derived | -80040000 | 22638000 Derived | -102678000 | -25685000 Derived | Source
|
| 2019 2019-01-01 – 2019-12-31 | 175338000 | 312699000 Derived | -137361000 | 9066000 Derived | -146427000 | -58409000 Derived | Source
|
| 2020 2020-01-01 – 2020-12-31 | 198321000 | 374484000 Derived | -176163000 | -6732000 Derived | -169431000 | -49510000 Derived | Source
|
| 2021 2021-01-01 – 2021-12-31 | 131836000 | 331261000 Derived | -199425000 | -19334000 Derived | -180091000 | -19893000 Derived | Source
|
| 2022 2022-01-01 – 2022-12-31 | 109460000 | 429273000 Derived | -319813000 | -41331000 Derived | -278482000 | -186482000 Derived | Source
|
| 2023 2023-01-01 – 2023-12-31 | 145238000 | 533376000 Derived | -388138000 | -276739000 Derived | -111399000 | -280689000 Derived | Source
|
| 2024 2024-01-01 – 2024-12-31 | 233175000 | 557002000 Derived | -323827000 | -2282000 Derived | -321545000 | Unavailable | Source
|
| 2025 2025-01-01 – 2025-12-31 | 490728000 | 553552000 Derived | -62824000 | -37278000 Derived | -25546000 | Unavailable | Source
|
Amounts are exact, in USD.
Sales over time and how quickly they are changing.
Revenue reported for each complete financial period.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2016 | Revenue | 133591000 |
|
| 2017 | Revenue | 154937000 |
|
| 2018 | Revenue | 164246000 |
|
| 2019 | Revenue | 175338000 |
|
| 2020 | Revenue | 198321000 |
|
| 2021 | Revenue | 131836000 |
|
| 2022 | Revenue | 109460000 |
|
| 2023 | Revenue | 145238000 |
|
| 2024 | Revenue | 233175000 |
|
| 2025 | Revenue | 490728000 |
|
Change in revenue from the same financial period one year earlier.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2016 | Year over year | No prior comparable period |
|
| 2017 | Year over year | 16% |
|
| 2018 | Year over year | 6% |
|
| 2019 | Year over year | 6.8% |
|
| 2020 | Year over year | 13.1% |
|
| 2021 | Year over year | -33.5% |
|
| 2022 | Year over year | -17% |
|
| 2023 | Year over year | 32.7% |
|
| 2024 | Year over year | 60.5% |
|
| 2025 | Year over year | 110.5% |
|
How much revenue becomes profit, and how much cash operations generate.
Operating income, net income and free cash flow as a share of revenue.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2016 | Operating margin | -43.6% |
|
| 2017 | Operating margin | -34.7% |
|
| 2018 | Operating margin | -48.7% |
|
| 2019 | Operating margin | -78.3% |
|
| 2020 | Operating margin | -88.8% |
|
| 2021 | Operating margin | -151.3% |
|
| 2022 | Operating margin | -292.2% |
|
| 2023 | Operating margin | -267.2% |
|
| 2024 | Operating margin | -138.9% |
|
| 2025 | Operating margin | -12.8% |
|
| 2016 | Net margin | -35.9% |
|
| 2017 | Net margin | -38.6% |
|
| 2018 | Net margin | -62.5% |
|
| 2019 | Net margin | -83.5% |
|
| 2020 | Net margin | -85.4% |
|
| 2021 | Net margin | -136.6% |
|
| 2022 | Net margin | -254.4% |
|
| 2023 | Net margin | -76.7% |
|
| 2024 | Net margin | -137.9% |
|
| 2025 | Net margin | -5.2% |
|
| 2016 | Free cash flow margin | -3.6% |
|
| 2017 | Free cash flow margin | 4.2% |
|
| 2018 | Free cash flow margin | -15.6% |
|
| 2019 | Free cash flow margin | -33.3% |
|
| 2020 | Free cash flow margin | -25% |
|
| 2021 | Free cash flow margin | -15.1% |
|
| 2022 | Free cash flow margin | -170.4% |
|
| 2023 | Free cash flow margin | -193.3% |
|
| 2024 | Free cash flow margin | Not reported |
|
| 2025 | Free cash flow margin | Not reported |
|
Cash generated by the company’s normal business operations.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2016 | Operating cash flow | -3441000 |
|
| 2017 | Operating cash flow | 7403000 |
|
| 2018 | Operating cash flow | -24958000 |
|
| 2019 | Operating cash flow | -58214000 |
|
| 2020 | Operating cash flow | -42743000 |
|
| 2021 | Operating cash flow | -14792000 |
|
| 2022 | Operating cash flow | -186291000 |
|
| 2023 | Operating cash flow | -280021000 |
|
| 2024 | Operating cash flow | -237475000 |
|
| 2025 | Operating cash flow | 37784000 |
|
Operating cash flow minus capital expenditure for the same period and unit.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2016 | Free cash flow | -4869000 |
|
| 2017 | Free cash flow | 6516000 |
|
| 2018 | Free cash flow | -25685000 |
|
| 2019 | Free cash flow | -58409000 |
|
| 2020 | Free cash flow | -49510000 |
|
| 2021 | Free cash flow | -19893000 |
|
| 2022 | Free cash flow | -186482000 |
|
| 2023 | Free cash flow | -280689000 |
|
| 2024 | Free cash flow | Unavailable |
|
| 2025 | Free cash flow | Unavailable |
|
Liabilities and short-term ability to meet obligations at each period end.
Total liabilities as a share of total assets.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2016 | Liabilities / assets | 41.4% |
|
| 2017 | Liabilities / assets | 43.7% |
|
| 2018 | Liabilities / assets | 55.1% |
|
| 2019 | Liabilities / assets | 63.4% |
|
| 2020 | Liabilities / assets | 65.2% |
|
| 2021 | Liabilities / assets | 61.1% |
|
| 2022 | Liabilities / assets | 93.6% |
|
| 2023 | Liabilities / assets | 74.5% |
|
| 2024 | Liabilities / assets | 90.1% |
|
| 2025 | Liabilities / assets | 81% |
|
Current assets divided by current liabilities.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2016 | Current assets / current liabilities | 3.99× |
|
| 2017 | Current assets / current liabilities | 3.8× |
|
| 2018 | Current assets / current liabilities | 4.74× |
|
| 2019 | Current assets / current liabilities | 4.5× |
|
| 2020 | Current assets / current liabilities | 4.43× |
|
| 2021 | Current assets / current liabilities | 4.7× |
|
| 2022 | Current assets / current liabilities | 3.42× |
|
| 2023 | Current assets / current liabilities | 3.47× |
|
| 2024 | Current assets / current liabilities | 2.08× |
|
| 2025 | Current assets / current liabilities | 2.74× |
|
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2016 2016-01-01 – 2016-12-31 | −USD 47.9 million Exact valueExact value: -47903000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 3.44 million Exact valueExact value: -3441000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 1.43 million Exact valueExact value: 1428000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 4.87 million Calculation and evidence-3441000 − 1428000 USD Exact free cash flow: -4869000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2017 2017-01-01 – 2017-12-31 | −USD 59.73 million Exact valueExact value: -59731000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 7.4 million Exact valueExact value: 7403000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 887,000 Exact valueExact value: 887000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 6.52 million Calculation and evidence7403000 − 887000 USD Exact free cash flow: 6516000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2018 2018-01-01 – 2018-12-31 | −USD 102.68 million Exact valueExact value: -102678000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 24.96 million Exact valueExact value: -24958000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 727,000 Exact valueExact value: 727000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 25.69 million Calculation and evidence-24958000 − 727000 USD Exact free cash flow: -25685000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2019 2019-01-01 – 2019-12-31 | −USD 146.43 million Exact valueExact value: -146427000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 58.21 million Exact valueExact value: -58214000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 195,000 Exact valueExact value: 195000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 58.41 million Calculation and evidence-58214000 − 195000 USD Exact free cash flow: -58409000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2020 2020-01-01 – 2020-12-31 | −USD 169.43 million Exact valueExact value: -169431000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 42.74 million Exact valueExact value: -42743000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 6.77 million Exact valueExact value: 6767000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 49.51 million Calculation and evidence-42743000 − 6767000 USD Exact free cash flow: -49510000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2021 2021-01-01 – 2021-12-31 | −USD 180.09 million Exact valueExact value: -180091000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 14.79 million Exact valueExact value: -14792000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 5.1 million Exact valueExact value: 5101000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 19.89 million Calculation and evidence-14792000 − 5101000 USD Exact free cash flow: -19893000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2022 2022-01-01 – 2022-12-31 | −USD 278.48 million Exact valueExact value: -278482000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 186.29 million Exact valueExact value: -186291000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 191,000 Exact valueExact value: 191000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 186.48 million Calculation and evidence-186291000 − 191000 USD Exact free cash flow: -186482000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2023 2023-01-01 – 2023-12-31 | −USD 111.4 million Exact valueExact value: -111399000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 280.02 million Exact valueExact value: -280021000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 668,000 Exact valueExact value: 668000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 280.69 million Calculation and evidence-280021000 − 668000 USD Exact free cash flow: -280689000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2024 2024-01-01 – 2024-12-31 | −USD 321.55 million Exact valueExact value: -321545000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 237.48 million Exact valueExact value: -237475000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2025 2025-01-01 – 2025-12-31 | −USD 25.55 million Exact valueExact value: -25546000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 37.78 million Exact valueExact value: 37784000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
98 filings · 4,697 latest values · 4,697 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0001438533, 1438533, RTRX, TVTX, edgar:1438533, rtrx
Also known as Desert Gateway, Inc., RETROPHIN, INC., Retrophin, Inc., TRAVERE THERAPEUTICS, INC., Travere Therapeutics, Inc.